Request Sample
Request Methodology
Description
Global Multiplex Assays Market
The global multiple assays market is expected to be valued at US$ 2.995 million in market and growing at a CAGR of 4.95 % over the forecast period. Increase adoption of multiple assays compare to the traditional one because of the technology advancement like Nano technology which represents the ultra-miniaturization version of the conventional microarray is consider to be the key driver. More unit sample are required and high capital investment are anticipated to restrain which hung market growth during the forecast period of global multiplex assays market. Bio therapeutic R&D, cell gene therapy the global multiplex assay is the only approach hence opening up a intense of opportunity
Increase R&D Activities in Forensic Studies and Mutation Analysis
It is noticed that the global multiple assays market is influenced mainly by the number of R&D activities in forensic studies and mutation analysis which is the key factor causing the multiple assays market to grow. Accordingly, multi advantage properties include analyze multiple proteins simultaneously rather than having to run multiple assays to look for each protein separately. Running multiple assays means that there could be subtle variations in each run, which may impact the results hence boost up the global multiplex assay market. The ease with which STR profiles can be typed today has led to the development of large national databases containing STR profiles of millions of people suspected or convicted of crimes.
North America Dominates the Market Share in the Global Monoclonal Therapeutic Market
North America contributed major revenue followed by Europe and Asia Pacific. In 2019, North America region accounted huge growth rate and is anticipated to grow with a forecast year. However, it was an evident that the therapeutic market gaining interest in developing nations North America with a leading share of 44%. Development produced by well advanced healthcare and adopting new technology key factors that drive the growth of the market in this region and increase in patient population with Alzheimer disease. The European region is projected to observe a significant growth period due to increasing geriatric population included in system illness and chronic infection. Asia-Pacific is expected to register the highest CAGR during the forecast period contributing to the global multiple assay market.
Competition Assessment
Key player’s profiles in the global multiple assay market include:
- Thermo Fisher Scientific Inc
- Illumina Inc
- Bio Rad Laboratories Inc
- Qiagen, Abcam plc
- BD
- Merck Sharp & Dohme Corp
- Agilent Technologies
- Meso Scale Diagnostics LLC
- Randox Laboratories Ltd
- Quanterix, Bio-Techne
- Seegene Inc.
Key Developments:
- Market players have witnessed the strategic collaboration and acquisition to expand product portfolio and strengthen their position in the market to enhance the revenue of the company.
- In June 2018, QIAGEN (Germany) launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched along with a new generation of reagents that allows the most accurate quantification and qualitative analysis from complex microbiome samples. This product provides a comprehensive and robust profiling of bacterial and fungal communities. With this launch, one more product got added to the company’s product portfolio.
- In January 2016, Thermo Fisher Scientific acquired Affymetrix (U.S.). The acquisition of Affymetrix with Thermo Fisher Scientific helped Thermo Fisher Scientific Company in strengthening the biosciences field and creating new market opportunities for in genetic analysis
Global Multiplex Assays Market Report Description:
Global multiplex assays market report gives comprehensive outlook on multiplex assays market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global multiplex assays market gives historical, current, and future market sizes on the basis of product, type, application, technology, and region. This report studies global multiplex assays market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global multiplex assays market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global multiplex assays market
Key Findings of the Report:
- Global multiple assay market expanding at significant CAGR over 2020 to 2026 owing due to raising R&D activities in forensic studies and mutation analysis
- Based on region, North America accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
- Players focusing on innovation
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation
By Product
- Consumable
- Instrument
- Software Services
By Type
- Protein Multiplex Assay
- Planer Protein Assay
- Bead-based Protein Assay
- Nucleic Acid Multiplex Assay
- Planer Nucleic Acid Assay
- Bead-based Nucleic Acid Assay
- Other Nucleic Acid Assay
- Cell-based Multiplex Assay
By Technology
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex Real-time PCR
- Other Technology
By Application
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
- Clinical Diagnostic
End Users
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research Institutes
- Clinical laboratories
By Geography:
North America
- USA
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Location
GEOGRAPHY
